FindMyKOL

Susan Blaney, MD

Enriched profile

The Elise C. Young Chair in Pediatric Oncology, Director of Texas Children's Cancer and Hematology Centers, and Professor of Pediatrics at Baylor College of Medicine · Baylor College of Medicine

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyHematology / OncologyFocusGlioma Diagnosis and Treatment+4
Last active 2024FindMyKOL type: EliteLatest publication2024Online presenceNone verifiedPaymentsNone reportedNIH funding1997–2024Why? →

Susan Blaney is The Elise C. Young Chair in Pediatric Oncology, Director of Texas Children's Cancer and Hematology Centers, and Professor of Pediatrics at Baylor College of Medicine at Baylor College of Medicine. OpenAlex indexes 375 publications with 15,608 citations (h-index 75); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the FindMyKOL directory.

Data verified 17 Oct 2026

Overview

Updated 27 Oct 2026

Susan Blaney, MD, is The Elise C. Young Chair in Pediatric Oncology, Director of Texas Children's Cancer and Hematology Centers, and Professor of Pediatrics at Baylor College of Medicine. The public record shows 375 publications with 15,608 citations (h-index 75), centered on Glioma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Cancer therapeutics and mechanisms. It also documents an investigator role on 14 registered clinical trials, 6 NIH-funded awards (1997–2024).

  • Most recent indexed publication: 2024 · Journal of clinical oncology
  • Top research focus: Glioma Diagnosis and Treatment
  • 14 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Central Nervous System Neoplasms4 trialsNervous System Neoplasms4 trialsLeukemia (AML/ALL/CML/CLL)2 trialsLymphoma2 trialsMeningitis2 trialsNeuro-Oncology / Glioma1 trialHIV1 trialNeoplasm Metastasis1 trialLeukemia, Myeloid, Acute1 trialAcquired Immunodeficiency Syndrome1 trialPrecursor Cell Lymphoblastic Leukemia-Lymphoma1 trialHodgkin Disease1 trialST Elevation Myocardial Infarction1 trialMedulloblastoma1 trialBrain Neoplasms1 trialHerpes Zoster1 trialNeuroblastoma1 trialSarcoma

Research focus

OpenAlex concept fingerprint
Glioma Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchCancer therapeutics and mechanismsSarcoma Diagnosis and TreatmentPharmaceutical studies and practices

Works with

trial sponsors and companies reporting payments
Baylor College of MedicineClinical trials7Industry payments—National Cancer Institute (NCI)Clinical trials3Industry payments—Pediatric Brain Tumor ConsortiumClinical trials3Industry payments—Texas Children's Cancer CenterClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
375publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

15,608citations

Total citations across indexed works.

75h-index

Hirsch index (OpenAlex). i10-index 204.

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
6NIH grants · 1997–2024

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 26 Oct 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

All 14 trial records: search, sort and filter.Explore →

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

NIH funding

Updated 26 Oct 2026

6 NIH research awards on record, funded 1997–2024 per NIH RePORTER. The latest:

All 161 award records: search, sort and filter.Explore →

Congress activity

Updated 26 Oct 2026

59 congress contributions (2004–2017) across AACR, ASCO, ASTRO per OpenAlex. The most recent:

All 59 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 26 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Most-cited works

by citation count (OpenAlex)
  1. 01
    Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
    Article712 citations2013
    doi.org ↗
  2. 02
    Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy
    Article424 citations2005
    doi.org ↗
  3. 03
    Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study
    Article413 citations2017
    doi.org ↗
  4. 04
    Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma
    Article361 citations2001
    doi.org ↗
  5. 05
    Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group
    Article318 citations2005
    doi.org ↗
All 375 cited works: search, sort and filter.Explore →

Network

Updated 26 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Peter C. Adamson103Brenda J. Weigel82Stacey L. Berg79Murali Chintagumpala58Frank M. Balis57Mark Krailo57Joel M. Reid50Richard J. Gilbertson47Ashish Mark Ingle46Charlotte Hsieh Ahern40Donald Williams Parsons36Austin J. Stuckert35Hsiao‐Chi Chen34Amir Arabzade34Kelsey C. Bertrand34Charles Y. Lin34H. Courtney Hodges34Thomas F. Westbrook34Srinidhi Varadharajan34Sameer Agnihotri34Bryan Rivas34Stephen C. Mack34Benjamin Deneen34Maryam Fouladi34Kristian W. Pajtler33Minerva Solis33Yuen San Chan33Peter R. Wang33Brian J. Golbourn33Baoli Hu33Kathleen Kong33Luz A. De León33Claudia L. Kleinman33Dana Tlais33Kristen L. Karlin33Alisha Kardian33Stefan M. Pfister33Sarah Garrett Injac33Elizabeth Fox33Irtisha Singh33

Online presence

Updated 26 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    braintumor.org/news/national-brain-tumor-society-appoints-renowned-pediatric-oncologist-dr-susan-blaney-as-chief-scientific-officer

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →braintumor.org ↗
  • Other

    profiles.viictr.org/display/268174

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.viictr.org ↗
  • Other

    texaschildrens.org/find-a-doctor/susan-m-blaney-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →texaschildrens.org ↗
  • Other

    bcm.edu/people-search/susan-blaney-18483

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcm.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 26 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Vice Chair

    Children's Oncology Group (NCI-supported clinical trials group)

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texaschildrensnews.org ↗
  • Chief Scientific Officer

    National Brain Tumor Society

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →braintumor.org ↗
  • Member

    Hematology-Oncology Self-Assessment Team, American Board of Pediatrics

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texaschildrensnews.org ↗
  • David G. Poplack

    MD Chair in Pediatric Oncology

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texaschildrensnews.org ↗
  • Editor

    Pizzo and Poplack's Principles and Practice of Pediatric Oncology

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texaschildrensnews.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.